KNTE
Kinnate Biopharma Inc.
Orbimed Advisors LLC bought $4.1M of Kinnate Biopharma Inc.
Director and 10% owner
Bought$4,086,235
$2.80Price
1,460,932Shares
+331%Stake
What KNTE did for a copier
- $1,000 copied at Tue, May 9 open, $3.19
- $972
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Jun 22 close.
Orbimed Advisors LLC's record
34 other buys with 3 months of prices since 2016: on average −12.1% against the S&P 500, and 12 of 34 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 4. Filed Mon, May 8, 5:22 PM ET, after the close. Returns use the May 9 open and the Jun 22 close. Not investment advice.